Axonics, Inc. (AXNX)
USD 70.98
(N/A%)
USD 70.98
(N/A%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -26.05 Million USD | 88.88% |
| 2022 | -42.38 Million USD | 37.11% |
| 2021 | -67.39 Million USD | -25.36% |
| 2020 | -53.76 Million USD | 33.3% |
| 2019 | -80.59 Million USD | -150.8% |
| 2018 | -32.13 Million USD | -76.83% |
| 2017 | -18.17 Million USD | -3.95% |
| 2016 | -17.48 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -19.17 Million USD | -517.3% |
| 2024 Q2 | 6.33 Million USD | 133.02% |
| 2023 Q1 | -12.6 Million USD | -1931.4% |
| 2023 Q3 | -687 Thousand USD | -103.43% |
| 2023 Q2 | 20.02 Million USD | 258.95% |
| 2023 FY | -4.71 Million USD | 88.88% |
| 2023 Q4 | 4.59 Million USD | 769.0% |
| 2022 Q3 | -8.13 Million USD | 11.83% |
| 2022 Q4 | 688 Thousand USD | 108.46% |
| 2022 Q2 | -9.22 Million USD | 60.8% |
| 2022 Q1 | -23.53 Million USD | -33.11% |
| 2022 FY | -42.38 Million USD | 37.11% |
| 2021 Q1 | -21.61 Million USD | -98.66% |
| 2021 Q2 | -16.01 Million USD | 25.93% |
| 2021 Q3 | -16.5 Million USD | -3.07% |
| 2021 Q4 | -17.68 Million USD | -7.14% |
| 2021 FY | -67.39 Million USD | -25.36% |
| 2020 Q3 | -8.76 Million USD | 54.81% |
| 2020 Q2 | -19.4 Million USD | -31.96% |
| 2020 Q1 | -14.7 Million USD | 35.11% |
| 2020 Q4 | -10.88 Million USD | -24.08% |
| 2020 FY | -53.76 Million USD | 33.3% |
| 2019 Q3 | -25.04 Million USD | -29.98% |
| 2019 Q1 | -13.61 Million USD | -44.1% |
| 2019 FY | -80.59 Million USD | -150.8% |
| 2019 Q4 | -22.66 Million USD | 9.52% |
| 2019 Q2 | -19.27 Million USD | -41.49% |
| 2018 Q2 | -8.61 Million USD | -32.06% |
| 2018 FY | -32.13 Million USD | -76.83% |
| 2018 Q4 | -9.45 Million USD | -25.31% |
| 2018 Q3 | -7.54 Million USD | 12.49% |
| 2018 Q1 | -6.52 Million USD | -32.15% |
| 2017 Q1 | -4.32 Million USD | 0.0% |
| 2017 Q2 | -4.32 Million USD | 0.0% |
| 2017 Q3 | -4.59 Million USD | -6.29% |
| 2017 Q4 | -4.93 Million USD | -7.52% |
| 2017 FY | -18.17 Million USD | -3.95% |
| 2016 FY | -17.48 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -81.443% |
| Cerus Corporation | -30.05 Million USD | 13.297% |
| OrthoPediatrics Corp. | -25.76 Million USD | -1.129% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -145.327% |
| Talis Biomedical Corporation | -66.81 Million USD | 61.001% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -50.653% |
| Inogen, Inc. | -109.38 Million USD | 76.179% |
| Spectral AI, Inc. | -12.98 Million USD | -100.685% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 58.368% |
| CVRx, Inc. | -43.1 Million USD | 39.547% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -638.577% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -109.664% |
| Orthofix Medical Inc. | -139.11 Million USD | 81.269% |
| Venus Concept Inc. | -28.3 Million USD | 7.955% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 51.771% |
| Bioventus Inc. | -81.72 Million USD | 68.116% |
| BrainsWay Ltd. | -4.92 Million USD | -428.861% |
| Envoy Medical, Inc. | -18.37 Million USD | -41.838% |
| electroCore, Inc. | -18.8 Million USD | -38.564% |
| IceCure Medical Ltd | -15.57 Million USD | -67.289% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 46.254% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -50.897% |
| MaxCyte, Inc. | -48.29 Million USD | 46.051% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -117.954% |
| Nexalin Technology, Inc. | -5.69 Million USD | -357.438% |
| PAVmed Inc | -68.79 Million USD | 62.124% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 53.933% |
| RxSight, Inc. | -50.08 Million USD | 47.974% |
| Sight Sciences, Inc. | -57.27 Million USD | 54.505% |
| SI-BONE, Inc. | -46.93 Million USD | 44.478% |
| TELA Bio, Inc. | -44.07 Million USD | 40.88% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 51.88% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 49.333% |
| LivaNova PLC | -68.49 Million USD | 61.959% |
| 908 Devices Inc. | -42.75 Million USD | 39.059% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 84.972% |
| Nemaura Medical Inc. | -9.59 Million USD | -171.562% |
| NeuroPace, Inc. | -27.17 Million USD | 4.111% |
| LENSAR, Inc. | -12.22 Million USD | -113.075% |
| Apyx Medical Corporation | -17.25 Million USD | -50.976% |
| Cutera, Inc. | -156.23 Million USD | 83.321% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -202.848% |
| BioSig Technologies, Inc. | -28.51 Million USD | 8.61% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 70.268% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -16.087% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 123.364% |
| Outset Medical, Inc. | -169.77 Million USD | 84.652% |
| IRIDEX Corporation | -10 Million USD | -160.388% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 76.132% |
| IRadimed Corporation | 20.03 Million USD | 230.054% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -216.034% |
| INVO Bioscience, Inc. | -6.76 Million USD | -285.051% |
| Telesis Bio, Inc. | -35.15 Million USD | 25.869% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 281.835% |
| Varex Imaging Corporation | 32.1 Million USD | 181.174% |
| Quipt Home Medical Corp. | 3.91 Million USD | 764.889% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -114.761% |
| Pulmonx Corporation | -61.93 Million USD | 57.928% |
| Dynatronics Corporation | -2.27 Million USD | -1046.346% |
| Modular Medical, Inc. | -17.52 Million USD | -48.651% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -77.997% |
| Semler Scientific, Inc. | 22.25 Million USD | 217.079% |
| InMode Ltd. | 195.66 Million USD | 113.317% |
| Bruker Corporation | 436.9 Million USD | 105.964% |
| Cytosorbents Corporation | -31.2 Million USD | 16.509% |
| DexCom, Inc. | 597.7 Million USD | 104.36% |
| Align Technology, Inc. | 643.33 Million USD | 104.05% |
| Viveve Medical, Inc. | -21.55 Million USD | -20.897% |
| ZimVie Inc. | -30.93 Million USD | 15.779% |
| Movano Inc. | -29.69 Million USD | 12.236% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 6.421% |
| Nexalin Technology, Inc. | -5.69 Million USD | -357.438% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -638.577% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 88.828% |
| Profound Medical Corp. | -28.61 Million USD | 8.943% |
| Insulet Corporation | 220 Million USD | 111.844% |
| enVVeno Medical Corporation | -25.23 Million USD | -3.245% |
| Surmodics, Inc. | -5.64 Million USD | -361.594% |
| iCAD, Inc. | -7.68 Million USD | -238.887% |
| Nuwellis, Inc. | -17.63 Million USD | -47.799% |
| Biotricity, Inc. | -8.82 Million USD | -195.154% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 79.181% |
| Aethlon Medical, Inc. | -12.63 Million USD | -106.203% |
| InspireMD, Inc. | -21.14 Million USD | -23.242% |
| PAVmed Inc. | -68.79 Million USD | 62.124% |
| BIOLASE, Inc. | -17.93 Million USD | -45.27% |
| Beyond Air, Inc. | -63 Million USD | 58.644% |
| FONAR Corporation | 16.53 Million USD | 257.583% |
| AxoGen, Inc. | -21.46 Million USD | -21.41% |
| Vivani Medical, Inc. | -26.96 Million USD | 3.367% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 244.432% |
| Inari Medical, Inc. | -14.03 Million USD | -85.697% |
| UFP Technologies, Inc. | 57.66 Million USD | 145.188% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -428.797% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -313.225% |
| Tenon Medical, Inc. | -15.72 Million USD | -65.683% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -248.635% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 38.985% |
| AdaptHealth Corp. | -598.4 Million USD | 95.646% |
| Sintx Technologies, Inc. | -13.35 Million USD | -95.067% |
| NanoVibronix, Inc. | -3.43 Million USD | -658.353% |
| Quanterix Corporation | -49.7 Million USD | 47.572% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -114.761% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -6721.204% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 92.209% |
| TransMedics Group, Inc. | -28.72 Million USD | 9.294% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -10.355% |
| NeuroMetrix, Inc. | -7.15 Million USD | -264.356% |
| Hyperfine, Inc. | -48.11 Million USD | 45.844% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 59.928% |
| Biomerica, Inc. | -6.36 Million USD | -309.251% |
| Bone Biologics Corporation | -9.42 Million USD | -176.37% |
| AVITA Medical, Inc. | -40.4 Million USD | 35.506% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -152.705% |
| Silk Road Medical, Inc | -59.27 Million USD | 56.038% |